Advertisement
Loading...

Geron Corporation

GERN•NASDAQ
Healthcare
Biotechnology
$1.28
$0.02(1.59%)
U.S. Market opens in 1h 34m
Advertisement

Geron Corporation (GERN) Stock Overview

Explore Geron Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap821.1M
P/E Ratio-12.31
EPS (TTM)$-0.11
ROE-0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$1.87
3 Months$3.63
1 Year Target$0.00

GERN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Geron Corporation (GERN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.31 and a market capitalization of 821.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.59%
5-Day Change
3.23%
1-Month Change
-14.67%
3-Month Change
-25.58%
6-Month Change
10.34%
Year-to-Date (YTD) Change
-3.03%
1-Year Change
-14.09%
3-Year Change
-59.11%
5-Year Change
-4.48%
All-Time (Max) Change
-82.54%

Contact Information

https://www.geron.com
650 473 7700
919 East Hillsdale Boulevard, Foster City, CA, 94404

Company Facts

229 Employees
IPO DateJul 31, 1996
CountryUS
Actively Trading

Frequently Asked Questions